Stay updated on CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial

Sign up to get notified when there's something new on the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov page displaying a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T14:32:29.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-12T14:36:12.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study details with an error screen.
    Difference
    20%
    Check dated 2026-09-21T19:56:28.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page shows a revision label updated from v3.6.5 to v3.6.6, reflecting a deployment/version update.
    Difference
    0.0%
    Check dated 2026-08-31T17:21:38.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision: v3.6.5 replaces v3.6.4, indicating a minor update to the page's platform or content management. This update does not alter the study details or eligibility information presented on the page.
    Difference
    0.0%
    Check dated 2026-08-09T22:43:58.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The page's revision label has been updated to v3.6.4, indicating a minor system or documentation update. No study information or visible content has changed.
    Difference
    0.0%
    Check dated 2026-07-26T13:27:08.000Z thumbnail image

Stay in the know with updates to CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CD40 Agonist APX005M + Nivolumab in Combo: Clinical Trial page.